A 7-day course of antibiotics for patients hospitalized with bloodstream infections was just as effective as a 14-day course, ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

(Corrects headline, paragraph 1 and 2 in Oct. 17 story to show the drug reduced medically attended lower respiratory ...

In some good news for women battling locally advanced cervical cancer, new research shows that adding six weeks of ...

Now, the researchers have demonstrated the approach's potential in a pilot study on blood cultures from patients undergoing ...

GSK's gepotidacin, an oral antibiotic for uUTIs, could be the first in over 20 years. The FDA granted Priority Review with a ...

Biosimilars are safe, effective, and well-tolerated for psoriasis treatment, providing significant cost savings for the ...

Through experiments on mice infected with a herpes virus, scientists discovered an immune system sensor that detects viral ...

However, their value in the management of uncomplicated skin infections is not yet clearly defined. This literature review discusses various topical antibiotic treatment options for uncomplicated ...

According to the CDC, respiratory infections caused by the bacteria Mycoplasma pneumoniae have increased in the U.S. over the ...

Clarametyx reports progress on study of antibody therapy CMTX-101 for infections associated with CF, to begin phase 2a portion of the trial: Columbus, Ohio Saturday, October 19, 2 ...

Scientists and doctors have suspected for years that one cause of the mysterious condition known as long COVID may be ...